FinTechFunding

Genetic Technologies: Appoints Simon Morriss as CEO

  • Molecular diagnostics company Genetic Technologies (GTG) has appointed Simon Morriss as Chief Executive Officer as of February 2021
  • Genetic Technologies also offer predictive testing and assessment tools to empower physicians to proactively manage patient health
  • Along with a fixed salary of $350,000, Simon Morriss will be eligible to receive 60 million performance rights on commencement for nil consideration
  • Simon Moriss has over 20 years of experience within the pharmaceutical and healthcare industries
  • Additionally, the board has announced George Muchnicki, acting CEO since September 2019, will step into the role of Chief Medical Officer and Executive Director
  • Genetic Technologies shares are up 6.67 percent, trading at 0.8 cents per share
Previous article
Simplex: Becomes Visa Principal Member
Next article
Thoma Bravo: Completes Strategic Growth Investment in Venafi
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...
FinTech

Hacked DeFi Platform Drift Secures Funds to Repay Customers

Drift plans to relaunch with Tether support after addressing security issues.Highlights: Drift DeFi platform has secured funds after...
FinTech

Business Banking Fintech Slash Reaches Unicorn Status

The fintech startup achieves a valuation of over $1 billion.Highlights: Slash has been valued at over $1 billion.The...
FinTech

Amex Strengthens Digital Services with AI Expense Management Acquisition

American Express to acquire Hyper to enhance its business offerings.Highlights: American Express announces the acquisition of AI startup...